Free Republic 1st Qtr 2022 Fundraising Target: $82,000 Receipts & Pledges to-date: $18,941
23%  
Woo hoo!! And the first 23% is in!! Thank you all very much!! God bless.

Keyword: ixempra

Brevity: Headers | « Text »
  • Ixempra - A New Drug For Advanced Breast Cancer

    12/09/2007 9:47:38 PM PST · by Coleus · 1 replies · 64+ views
    cancer decisions ^ | December 9, 2007 | Ralph W. Moss, Ph.D.
    In October 2007, the FDA approved Ixempra (ixabepilone) for the treatment of advanced breast cancer. Specifically, the drug was approved for the treatment of patients whose metastatic or locally advanced breast cancer has become resistant to standard drugs such as anthracyclines, taxanes, and capecitabine (Xeloda). Ixempra is classified as a "microtubule inhibitor." It is thus similar to the taxanes but is said by the manufacturer, Bristol-Myers, to be somewhat less toxic. "Previously, patients with aggressive metastatic or locally advanced breast cancer no longer responding to currently available chemotherapies had limited treatment options," said Linda Vahdat, M.D., of New York-Presbyterian Hospital/Weill...